Low Complement C4 Predicts Improvement of Kidney Function After Direct‐Acting Antiviral Therapy for Hepatitis C Virus

Direct‐acting antiviral therapies (DAAs) may improve kidney function and proteinuria in certain patients with hepatitis C infection (HCV) and chronic kidney disease (CKD). To improve our understanding of HCV‐mediated kidney dysfunction, we aimed to evaluate the baseline predictors of improvement in...

Descripción completa

Detalles Bibliográficos
Autores principales: Sise, Meghan E., Strohbehn, Ian, Chute, Donald, Corey, Kathleen E., Fusco, Dahlene N., Sabbisetti, Venkata S, Waikar, Sushrut S., Chung, Raymond T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395066/
https://www.ncbi.nlm.nih.gov/pubmed/32766479
http://dx.doi.org/10.1002/hep4.1528

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395066/
https://www.ncbi.nlm.nih.gov/pubmed/32766479
http://dx.doi.org/10.1002/hep4.1528

Ejemplares similares